ArticleAnnals of translational medicine2020
New peptidendrocins and anticancer chartreusin from an endophytic bacterium of
Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 25 citations in OpenAlex.
- Characterization and biological activities of endophytic bacteria from Vernonia anthelmintica flowers.Folia microbiologica · 2026Article
- Peptides in plant-microbe interactions: Functional diversity and pharmacological applications.Cell surface (Amsterdam, Netherlands) · 2025Review
- Neuroprotective effects of dendrobium endophytes metabolites in SH-SY5Y cells via the Nrf2/Keap1 pathway.Heliyon · 2024Article
- Endophytic bacterial community structure and diversity of the medicinal plant Mirabilis himalaica from different locations.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Article
- Endophytic Microbes from Medicinal Plants in Fenghuang Mountain as a Source of Antibiotics.Molecules (Basel, Switzerland) · 2023Article
- Bioactivity and toxicity of coumarins from African medicinal plants.Frontiers in pharmacology · 2023Review
- Benefit Effect ofEvidence-based complementary and alternative medicine : eCAM · 2021Article
- Huoshanmycins A‒C, New Polyketide Dimers Produced by EndophyticFrontiers in chemistry · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndophyte has now become a potential source for the discovery of novel natural products, as they participate in biochemical pathways of their hosts and produce analogous or novel bioactive compounds. As an epiphytic plant,
methodsthe plant tissues were cut and cultured on agar plates to isolate and purify the endophytic bacteria from
resultsFifty-eight endophytic strains representing 9 genera were obtained, with 50% of strains were
conclusionsThis study highlights the endophytic bacteria from medical plant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.